Zonare Medical Systems upgraded its z.one ultrasound system with the introduction of two new transducers, calculation packages, and a program that automatically recognizes and adjusts for differences in body sound propagation.
Zonare Medical Systems upgraded its z.one ultrasound system with the introduction of two new transducers, calculation packages, and a program that automatically recognizes and adjusts for differences in body sound propagation.
The new transducers expand the system's imaging capabilities and applications, according to the company. The new P10-4 transducer is designed for neonatal, infant, and pediatric imaging. The transducer design provides a comfortable grip for scanning through isolettes and very small acoustic windows. The P10-4 offers up to seven different frequencies, including harmonic imaging at 8.0 MHz, two color Doppler frequencies, and three B-mode frequencies.
The small footprint of the P4-1 transducer addresses clinicians' need for easy access in abdominal and ob/gyn sonography, providing flexibility with nine frequencies. The transducer can penetrate up to 30 cm.
The z.one system's new calculation packages address abdominal and venous imaging. The packages enable sonographers to use a protocol checklist with reports that include organ sizes, Doppler results, and a section for medical notes or comments.
The sound speed compensation program automatically adjusts the sound speed based on differences in patient body habitus, thereby optimizing clinical images, according to Zonare.
FDA Clears AI-Powered Ultrasound Software for Cardiac Amyloidosis Detection
November 20th 2024The AI-enabled EchoGo® Amyloidosis software for echocardiography has reportedly demonstrated an 84.5 percent sensitivity rate for diagnosing cardiac amyloidosis in heart failure patients 65 years of age and older.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.